GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 116 filers reported holding GOSSAMER BIO INC in Q2 2021. The put-call ratio across all filers is 7.76 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $135,358 | -56.9% | 112,798 | -54.8% | 0.00% | -50.0% |
| Q1 2023 | $314,133 | -11.4% | 249,312 | +52.6% | 0.00% | 0.0% |
| Q4 2022 | $354,576 | -94.2% | 163,399 | -68.1% | 0.00% | -94.1% |
| Q3 2022 | $6,131,000 | +1031.2% | 511,791 | +691.1% | 0.03% | +1033.3% |
| Q2 2022 | $542,000 | -35.2% | 64,696 | -32.8% | 0.00% | -57.1% |
| Q1 2022 | $836,000 | +29.8% | 96,262 | +69.0% | 0.01% | +16.7% |
| Q4 2021 | $644,000 | -31.7% | 56,958 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $943,000 | +727.2% | 75,018 | +432.2% | 0.01% | +1100.0% |
| Q2 2021 | $114,000 | -71.4% | 14,096 | -67.3% | 0.00% | -80.0% |
| Q1 2021 | $398,000 | +161.8% | 43,054 | +173.1% | 0.01% | +150.0% |
| Q4 2020 | $152,000 | -74.8% | 15,765 | -67.6% | 0.00% | -77.8% |
| Q3 2020 | $604,000 | +18.9% | 48,697 | +24.6% | 0.01% | 0.0% |
| Q2 2020 | $508,000 | – | 39,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 8,055,916 | $6,708,967 | 4.36% |
| Velan Capital Investment Management LP | 3,065,136 | $2,552,645 | 2.06% |
| Monashee Investment Management LLC | 5,304,212 | $4,417,348 | 1.84% |
| CVI Holdings, LLC | 976,108 | $812,903 | 1.61% |
| Samsara BioCapital, LLC | 6,130,268 | $5,105,287 | 1.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 6,130,268 | $5,105,287 | 1.55% |
| Opaleye Management Inc. | 4,754,200 | $3,959,298 | 1.29% |
| Octagon Capital Advisors LP | 8,187,883 | $6,818,869 | 1.05% |
| NEA Management Company, LLC | 15,727,942 | $13,098,230 | 1.01% |
| GREAT POINT PARTNERS LLC | 6,230,272 | $5,188,571 | 0.94% |